blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2994152

EP2994152 - CONJUGATES FOR PROTECTION FROM NEPHROTOXIC ACTIVE SUBSTANCES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.06.2019
Database last updated on 31.05.2024
FormerThe patent has been granted
Status updated on  13.07.2018
FormerGrant of patent is intended
Status updated on  08.05.2018
FormerExamination is in progress
Status updated on  20.02.2017
Most recent event   Tooltip23.07.2021Lapse of the patent in a contracting state
New state(s): MT		published on 25.08.2021  [2021/34]
Applicant(s)For all designated states
Merck Patent GmbH
Frankfurter Strasse 250
64293 Darmstadt / DE
[2016/11]
Inventor(s)01 / KUEBELBECK, Armin
Augartenstrasse 45
64625 Bensheim / DE
02 / LARBIG, Gregor
Hauptstrasse 13
63571 Gelnhausen / DE
03 / ARNOLD, Stefan
Schubertstrasse 10A
64839 Muenster / DE
04 / MIER, Walter
Brueckweg 21
64673 Bensheim / DE
05 / HABERKORN, Uwe
Königsäcker 82
67823 Schwetzingen / DE
 [2016/11]
Application number, filing date14718515.116.04.2014
[2016/11]
WO2014EP01025
Priority number, dateEP2013000243107.05.2013         Original published format: EP 13002431
[2016/11]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2014180533
Date:13.11.2014
Language:DE
[2014/46]
Type: A2 Application without search report 
No.:EP2994152
Date:16.03.2016
Language:DE
The application published by WIPO in one of the EPO official languages on 13.11.2014 takes the place of the publication of the European patent application.
[2016/11]
Type: B1 Patent specification 
No.:EP2994152
Date:15.08.2018
Language:DE
[2018/33]
Search report(s)International search report - published on:EP22.01.2015
ClassificationIPC:A61K51/08, C07K7/08
[2018/21]
CPC:
A61K51/08 (EP,US); A61K47/64 (US); A61K31/192 (EP,US);
A61K31/385 (EP,US); A61K47/645 (EP,US); A61P13/12 (EP);
C07K7/08 (EP,US) (-)
Former IPC [2016/11]A61K38/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/11]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:KONJUGATE ZUM SCHUTZ VOR NEPHROTOXISCHEN WIRKSTOFFEN[2016/11]
English:CONJUGATES FOR PROTECTION FROM NEPHROTOXIC ACTIVE SUBSTANCES[2016/11]
French:CONJUGUÉS OFFRANT UNE PROTECTION CONTRE LES SUBSTANCES ACTIVES NÉPHROTOXIQUES[2016/11]
Entry into regional phase03.09.2015National basic fee paid 
03.09.2015Designation fee(s) paid 
03.09.2015Examination fee paid 
Examination procedure03.09.2015Examination requested  [2016/11]
03.06.2016Amendment by applicant (claims and/or description)
07.10.2016Despatch of a communication from the examining division (Time limit: M04)
13.02.2017Reply to a communication from the examining division
30.05.2017Despatch of a communication from the examining division (Time limit: M04)
14.06.2017Reply to a communication from the examining division
20.09.2017Despatch of a communication from the examining division (Time limit: M04)
21.12.2017Reply to a communication from the examining division
09.05.2018Communication of intention to grant the patent
09.07.2018Fee for grant paid
09.07.2018Fee for publishing/printing paid
09.07.2018Receipt of the translation of the claim(s)
Opposition(s)16.05.2019No opposition filed within time limit [2019/30]
Fees paidRenewal fee
11.04.2016Renewal fee patent year 03
10.04.2017Renewal fee patent year 04
11.04.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL15.08.2018
CY15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
MT15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
PT15.12.2018
AT16.04.2019
LT16.04.2019
LU16.04.2019
LV16.04.2019
BE30.04.2019
[2021/34]
Former [2021/26]AL15.08.2018
CY15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
PT15.12.2018
AT16.04.2019
LT16.04.2019
LU16.04.2019
LV16.04.2019
BE30.04.2019
Former [2020/51]AL15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
PT15.12.2018
AT16.04.2019
LT16.04.2019
LU16.04.2019
LV16.04.2019
BE30.04.2019
Former [2020/29]AL15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
PT15.12.2018
LT16.04.2019
LU16.04.2019
LV16.04.2019
BE30.04.2019
Former [2020/16]AL15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
TR15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
LT16.04.2019
LU16.04.2019
LV16.04.2019
BE30.04.2019
Former [2020/12]AL15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
LT16.04.2019
LU16.04.2019
LV16.04.2019
BE30.04.2019
Former [2020/08]AL15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
LT16.04.2019
LU16.04.2019
Former [2020/04]AL15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
LU16.04.2019
Former [2020/02]AL15.08.2018
CZ15.08.2018
EE15.08.2018
MC15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/26]AL15.08.2018
CZ15.08.2018
EE15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
SM15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/24]AL15.08.2018
CZ15.08.2018
EE15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
SK15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/22]AL15.08.2018
CZ15.08.2018
PL15.08.2018
RO15.08.2018
RS15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/12]AL15.08.2018
RS15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/11]RS15.08.2018
BG15.11.2018
GR16.11.2018
IS15.12.2018
Former [2019/08]IS15.12.2018
Cited inInternational search[XAI]WO2007022774  (ACTION PHARMA AS [DK], et al) [X] 1-5,13-16 * das ganze Dokument, insbesondere Seite 3, Zeilen 19-29; Seite 4, Zeilen 3-11; Seite 5, Zeilen 28-33; Seite 11, Zeilen 4-36; Seite 20, Zeilen 19-30; Seite 42, Zeile 28 bis Seite 43, Zeile 4; Seite 49, Zeile 11 bis Seite 50, Zeile 15; Seite 52, Zeilen 11-27; Seite 54, Zeilen 10-17; Ansprüche 1, 16-19, 21, 30, 34; Sequenzen 44, 46, 59, 64, 69, 93 * [A] 10-12[I] 6;
 [XDA]WO2011009539  (MERCK PATENT GMBH [DE], et al) [XD] 1 * das ganze Dokument, insbesondere Seite 43, Zeilen 10-11; Anspruch 1 * [A] 2-6,10-16;
 [XA]  - NORIKO IHARA ET AL, "Amplification of Inhibitory Activity of Catechin against Disease-Related Enzymes by Conjugation on Poly([epsilon]-lysine)", BIOMACROMOLECULES, (20040901), vol. 5, no. 5, doi:10.1021/bm049823x, ISSN 1525-7797, pages 1633 - 1636, XP055130525 [X] 1 * das ganze Dokument, insbesondere Schema 1 * [A] 2-6,10-16

DOI:   http://dx.doi.org/10.1021/bm049823x
 [A]  - EL-MOWAFY A M ET AL., "Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines", NATURAL PRODUCT RESEARCH, (201104), vol. 25, no. 8, pages 850 - 856, XP009179287 [A] 1 * das ganze Dokument, insbesondere Zusammenfassung *

DOI:   http://dx.doi.org/10.1080/14786419.2010.533669
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.